Sokei, J., Martino, O. D., Basse, M., Gabriel, N., York, C., Ferraro, F., Sykes, S. (2025). MTHFD2 is a selective metabolic vulnerability in AML that supports mitochondrial redox homeostasis and venetoclax resistance. Blood. https://doi.org/10.1182/blood-2025-755